The Real Cost of a Screen Failure at Your Site

Screen failures are treated as a fact of life in clinical research. They are, but they are also one of the largest uncompensated cost centers at most research sites. Understanding what a screen failure actually costs you — and which ones are avoidable — changes how you build your prescreening process.

What a screen failure actually costs

Start by adding up the real inputs for one screening visit at your site:

• Coordinator time for chart review, consenting, and visit conduct — often two to four hours end to end
• Physician or investigator time for history, exam, and eligibility sign-off
• Lab draws, ECGs, imaging, and any central-read or kit shipping costs
• Exam room occupancy that could have hosted a billable visit
• Data entry, source documentation, and query resolution after the fact

Many budgets reimburse screen failures at a reduced rate, cap the number reimbursed, or require documentation that the failure was unavoidable. The gap between your true cost and what the sponsor pays is the number that matters. Calculate it once per active protocol and post it where your recruitment team can see it.

Not all screen failures are equal

The useful distinction is between informative and preventable failures.

An informative failure is one where eligibility genuinely could not be determined before the visit: a central lab value, a washout confirmation, an imaging read, a protocol-specified rating scale. You paid to learn something only the screening visit could tell you. That is the cost of doing business.

A preventable failure is one where the disqualifying fact already existed in a chart, a prior visit note, or could have been captured in a five-minute phone call. Excluded concomitant medications, age or BMI thresholds, prior therapy exclusions, documented comorbidities, and distance-from-site logistics fall here. Every preventable failure is money your site spent to discover something it already knew.

Tag every screen failure with a reason code and sort them into these two buckets monthly. In most site datasets, the preventable share is larger than anyone expects, and it clusters around three or four recurring criteria per protocol.

Moving the eligibility decision earlier

Once you know which criteria are driving preventable failures, build them into the front of your funnel:

1. Rewrite your phone script around the top offenders. If excluded medications cause most failures, ask for a current medication list before anything else, not at the end of a fifteen-minute call.
2. Do a documented pre-visit chart pass. A ten-minute review against the three or four highest-yield exclusions saves a full visit when it hits.
3. Ask candidates to bring or send records before scheduling, not before screening. Confirmation of prior therapy or a recent lab panel often settles eligibility without a visit.
4. Flag soft logistical disqualifiers early — transportation, work schedules, caregiver availability. These do not appear in the protocol but produce late withdrawals that cost as much as a failure.

What to tell sponsors

Clean screen-failure data is also a negotiating asset. If you can show that a specific criterion produces a disproportionate share of failures at your site, you have a concrete case for a protocol amendment, a prescreening lab allowance, or better screen-failure reimbursement in the next contract. Sites that bring numbers to that conversation get taken seriously; sites that bring frustration do not.

The goal is not a zero screen-failure rate. A site with no screen failures is almost certainly screening too conservatively and under-enrolling. The goal is to stop paying full price to learn things you could have learned for free.